本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioRestorative Therapies, Inc.

1.55
-0.0400-2.52%
盘后1.560.0100+0.65%14:45 EDT
成交量:4.35万
成交额:6.79万
市值:1,163.24万
市盈率:-1.05
高:1.59
开:1.56
低:1.54
收:1.59
数据加载中...
2023/04/06

重要事件披露

8-K - Current report
2023/03/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/05

重要事件披露

8-K - Current report
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/09

重要事件披露

8-K - Current report
2022/09/13

重要事件披露

8-K - Current report
2022/08/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/13

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/07

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/29

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership